Closed
6.27 1.46
24h
Min
5.93
Max
6.37
Income | 19M -31M |
---|---|
Sales | 20M 33M |
EPS | -0.35 |
Profit margin | -94.108 |
Employees | 274 |
EBITDA | 19M -35M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +289.61% upside |
Next Earnings | 6 sie 2025 |
---|
Market Cap | 156M 544M |
---|---|
Previous open | 4.81 |
Previous close | 6.27 |
By Trading Central
Confidence
Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 24 USD 289.61%
High 39 USD
Low 15 USD
Based on 10 Wall Street analysts offering 12 month price targets forVerve Therapeutics Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$